EMSELEX

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Finland, Croatia, Ireland, Lithuania, Mexico, Netherlands, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug EMSELEX contains one active pharmaceutical ingredient (API):

1 Darifenacin UNII CR02EYQ8GV - DARIFENACIN HYDROBROMIDE

Darifenacin is a selective muscarinic M3 receptor antagonist (M3 SRA) in vitro. The M3 receptor is the major subtype that controls urinary bladder muscle contraction. It is not known whether this selectivity for the M3 receptor translates into any clinical advantage when treating symptoms of overactive bladder syndrome. Read about Darifenacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EMSELEX Prolonged-release tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BD10	Darifenacin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01754876, 01754899, 01754913, 01754994, 01755002, 01755019, 17421906, 17631118
Country: EE	Ravimiamet	Identifier(s): 1199998, 1200003, 1200014, 1200025, 1200036, 1200047, 1200058, 1200069, 1200070, 1200081, 1200092, 1200104, 1200115, 1200126
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 023047, 023124, 023146, 023193
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 109681, 109684, 367990, 367992, 374358, 374360, 376344, 376346, 381328, 381330
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1027975, 1027976, 1027977, 1027978, 1027979, 1027980, 1027981, 1027982, 1027983, 1027984, 1027985, 1027986, 1063750, 1063751, 1070290, 1070291, 1070292, 1070293, 1070294, 1070295, 1070296, 1070297, 1070298, 1070299, 1070300, 1070301, 1070302, 1070303
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 612M2005
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 78204, 78212
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100129630, 100129647
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66045001, W66045002, W66045003, W66045004, W66045005, W66045006, W66046001, W66046002, W66046003, W66046004, W66046005, W66046006
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699874080120, 8699874080137